Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 2308 to 2357 of 3228 in total 
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2308\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l7. [source:swissprot;acc:p18124]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3976.92\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3804.85\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04522\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2309\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
delta(14)-sterol reductase (ec 1.3.1.70) (c-14 sterol reductase) (sterol c14-reductase) (delta14-sr) (transmembrane 7 superfamily member 2) (another new gene 1) (putative sterol reductase sr-1). [source:swissprot;acc:o76062]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6960.96\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
7273.7\vspace{3pt}}}&\multirow{8}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.04493\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2310\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
lamin b receptor (integral nuclear envelope inner membrane protein) (lmn2r). [source:swissprot;acc:q14739]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2311\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
solute carrier family 27 member 3; fatty acid transport protein 3. [source:refseq;acc:nm\_024330]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6961.19\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7273.93\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2312\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
very-long-chain acyl-coa synthetase (ec 6.2.1.-) (very-long-chain- fatty-acid-coa ligase). [source:swissprot;acc:o14975]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6960.26\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7273.01\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2313\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
disrupter of silencing 10. [source:refseq;acc:nm\_020368]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6960.96\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7273.7\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2314\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
very long-chain acyl-coa synthetase homolog 1. [source:refseq;acc:nm\_014031]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6960.99\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7273.72\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2315\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
solute carrier family 27 (fatty acid transporter), member 5; very long-chain acyl-coa synthetase homolog 2; very long-chain acyl-coa synthetase-related protein; likely ortholog of mouse solute carrier family 27 (fatty acid transporter), member 5. [source:refseq;acc:nm\_012254]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6961.11\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7273.85\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2316\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
similar to cg7020 gene product (fragment). [source:sptrembl;acc:q96ib4]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6960.74\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7273.48\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2317\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
solute carrier family 27 (fatty acid transporter), member 4; fatty acid transport protein 4. [source:refseq;acc:nm\_005094]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6961.44\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7274.17\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04492\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2318\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin. [source:swissprot;acc:p02248]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7484.98\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7821.11\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04491\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2319\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
putative pre-mrna splicing factor rna helicase (atp-dependent rna helicase #3) (deah-box protein 16). [source:swissprot;acc:o60231]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6362.48\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6647.42\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.04478\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2320\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
t54 protein. [source:swissprot;acc:q92917]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2321\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna polymerase epsilon p17 subunit (dna polymerase epsilon subunit 3) (chromatin accessibility complex 17) (huchrac17) (chrac-17). [source:swissprot;acc:q9nrf9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3496.21\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3652.28\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04464\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2322\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mothers against decapentaplegic homolog 2 (smad 2) (mothers against dpp homolog 2) (mad-related protein 2) (hmad-2) (jv18-1) (hsmad2). [source:swissprot;acc:q15796]\vspace{3pt}}&\multirow{12}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6773.67\vspace{3pt}}}&\multirow{12}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
7075.51\vspace{3pt}}}&\multirow{12}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.04456\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2323\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mothers against decapentaplegic homolog 1 (smad 1) (mothers against dpp homolog 1) (mad-related protein 1) (transforming growth factor- beta signaling protein-1) (bsp-1) (hsmad1) (jv4-1). [source:swissprot;acc:q15797]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2324\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cop9 subunit 6 (mov34 homolog, 34 kd). [source:refseq;acc:nm\_006833]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2325\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mothers against decapentaplegic homolog 3 (smad 3) (mothers against dpp homolog 3) (mad3) (hmad-3) (mmad3) (jv15-2) (hsmad3). [source:swissprot;acc:q92940]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2326\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
histone deacetylase 11 (hd11). [source:swissprot;acc:q96db2]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2327\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ethanolamine kinase-like protein eki2 (flj10761). [source:swissprot;acc:q9nvf9]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2328\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ethanolamine kinase (ec 2.7.1.82) (eki). [source:swissprot;acc:q9hbu6]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2329\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hepatocellular carcinoma susceptibility protein; x 003 protein; hdcmc29p; hspc260; likely ortholog of mouse cd40 ligand-activated specific transcript 3 (clast3). [source:refseq;acc:nm\_020232]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2330\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cop9 constitutive photomorphogenic homolog subunit 5; jun activation domain-binding protein. [source:refseq;acc:nm\_006837]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2331\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mothers against decapentaplegic homolog 9 (smad 9) (mothers against dpp homolog 9) (smad9) (madh6). [source:swissprot;acc:o15198]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2332\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mothers against decapentaplegic homolog 5 (smad 5) (mothers against dpp homolog 5) (smad5) (hsmad5) (jv5-1). [source:swissprot;acc:q99717]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2333\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
thioredoxin, mitochondrial precursor (mt-trx) (thioredoxin 2). [source:swissprot;acc:q99757]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2334\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
lipopolysaccharide-binding protein precursor (lbp). [source:swissprot;acc:p18428]\vspace{3pt}}&\multirow{6}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5123.89\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5350.78\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.04428\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2335\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
microsomal signal peptidase 25 kda subunit (ec 3.4.-.-) (spase 25 kda subunit) (spc25). [source:swissprot;acc:q15005]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2336\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
uridine 5'-monophosphate synthase (ump synthase) [includes: orotate phosphoribosyltransferase (ec 2.4.2.10) (oprtase); orotidine 5'- phosphate decarboxylase (ec 4.1.1.23) (ompdecase)]. [source:swissprot;acc:p11172]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2337\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cleft lip and palate associated transmembrane protein 1. [source:refseq;acc:nm\_001294]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2338\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
bactericidal permeability-increasing protein precursor (bpi) (cap 57). [source:swissprot;acc:p17213]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2339\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
phospholipid transfer protein precursor (lipid transfer protein ii). [source:swissprot;acc:p55058]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2340\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
alpha crystallin c chain (small stress protein-like protein hsp22) (e2ig1) (protein kinase h11). [source:swissprot;acc:q9ujy1]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5607.81\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5855.72\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04421\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2341\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
heat shock 27 kda protein (hsp 27) (stress-responsive protein 27) (srp27) (estrogen-regulated 24 kda protein) (28 kda heat shock protein). [source:swissprot;acc:p04792]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5606.66\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5854.45\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0442\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2342\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
acetyl-coenzyme a synthetase, cytoplasmic (ec 6.2.1.1) (acetate--coa ligase) (acyl-activating enzyme) (acetyl-coa synthetase) (acs) (acecs). [source:swissprot;acc:q9nr19]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7007.72\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7317.15\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04416\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2343\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
40s ribosomal protein s5. [source:swissprot;acc:p46782]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3672.17\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3516.98\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04413\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2344\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
carboxypeptidase a5. [source:refseq;acc:nm\_080385]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
8353.97\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
8001.45\vspace{3pt}}}&\multirow{8}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.04406\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2345\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
carboxypeptidase b precursor (ec 3.4.17.2) (pancreas-specific protein) (pasp). [source:swissprot;acc:p15086]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2346\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
neutral and basic amino acid transport protein rbat (b(0,+)-type amino acid transport protein) (nbat) (d2h). [source:swissprot;acc:q07837]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2347\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ral guanine nucleotide exchange factor ralgps1a. [source:refseq;acc:nm\_014636]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6480.27\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6765.81\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2348\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ral-a exchange factor ralgps2. [source:refseq;acc:nm\_152663]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2349\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
aminoacylase-1 (ec 3.5.1.14) (n-acyl-l-amino-acid amidohydrolase) (acy-1). [source:swissprot;acc:q03154]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
8353.97\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8001.45\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2350\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
stip1 homology and u-box containing protein 1; serologically defined colon cancer antigen 7; carboxy terminus of hsp70p-interacting protein; heat shock protein a binding protein 2 (c-terminal). [source:refseq;acc:nm\_005861]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6480.27\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6765.81\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2351\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
carboxypeptidase a1 precursor (ec 3.4.17.1). [source:swissprot;acc:p15085]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
8353.97\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8001.45\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2352\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
coatomer epsilon subunit (epsilon-coat protein) (epsilon-cop). [source:swissprot;acc:o14579]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
8493.7\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8135.59\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04402\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2353\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
signal transducer and activator of transcription 5b. [source:swissprot;acc:p51692]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5516.82\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5758.48\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0438\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2354\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
signal transducer and activator of transcription 5a. [source:swissprot;acc:p42229]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5516.67\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5758.22\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04379\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2355\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
atrophin-1 interacting protein 1; activin receptor interacting protein 1; likely ortholog of mouse activin receptor interacting protein 1; atrophin-1 interacting protein a; membrane associated guanylate kinase 2; activin receptor interacting p. [source:refseq;acc:nm\_012301]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5262.6\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5492.58\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0437\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2356\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
signal transducer and activator of transcription 6 (il-4 stat). [source:swissprot;acc:p42226]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5515.12\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5755.63\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04361\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2357\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
signal transducer and activator of transcription 3 (acute-phase response factor). [source:swissprot;acc:p40763]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5514.85\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5755.17\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04358\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/